Get the Stockscreener App
1.7539
1.47%
-0.0261
Vivosim Labs Inc stock is traded at $1.7539, with a volume of 22,585.
It is down -1.47% in the last 24 hours and down -9.59% over the past month.
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
See More
Previous Close:
$1.78
Open:
$1.75
24h Volume:
22,585
Relative Volume:
0.36
Market Cap:
$4.56M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-9.12%
1M Performance:
-9.59%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.71
$1.88
1-Week Range:
$1.71
$1.92
52-Week Range:
$1.41
$2.37
Vivosim Labs Inc Stock (VIVS) Company Profile
Name
Vivosim Labs Inc
Sector
Industry
Phone
858-224-1000
Address
11555 SORRENTO VALLEY ROAD, SAN DIEGO
Compare VIVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VIVS
Vivosim Labs Inc
|
1.7539 | 4.63M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-18 | Initiated | H.C. Wainwright | Buy |
| Nov-10-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-25-17 | Initiated | Raymond James | Outperform |
| Aug-11-15 | Downgrade | Cantor Fitzgerald | Buy → Hold |
| Jun-29-15 | Initiated | Jefferies | Buy |
| Jun-29-15 | Initiated | Piper Jaffray | Overweight |
View All
Vivosim Labs Inc Stock (VIVS) Latest News
What risks could impact VivoSim Labs Inc. stock performanceJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - Newser
VivoSim Labs 2026 Q1 Earnings Losses Narrowed by 15% - AInvest
Visual analytics tools that track VivoSim Labs Inc. performanceFree Weekly Growth Stock Entry Point Alerts - Newser
Is VivoSim Labs Inc. stock ready for a breakoutBuy Point Strategy with Profit Protection - Newser
Custom watchlist performance reports with VivoSim Labs Inc.Daily Pattern Analysis with Return Forecast - Newser
VivoSim: Fiscal Q1 Earnings Snapshot - San Francisco Chronicle
VivoSim Labs Inc. Enters Reversal Setup in Weekly ChartsLow Capital High Return Stock Plans Reviewed - 선데이타임즈
Understanding VivoSim Labs Inc.’s price movementFree Entry and Exit Strategy Optimizer Tool - Newser
Quantitative breakdown of VivoSim Labs Inc. recent moveEntry Timing with Downside Risk Analysis - Newser
Signal strength of VivoSim Labs Inc. stock in tech scannersLow-Risk Reversal Pattern Analysis Tracker - Newser
Intraday pattern recognizer results for VivoSim Labs Inc.Free Daily Top Performing Stock Insights - Newser
How to forecast VivoSim Labs Inc. trends using time seriesFree Low Drawdown Real Time Trading Tips - Newser
How VivoSim Labs Inc. stock performs during market volatilitySteady Return Plan Based on Data Analysis - Newser
How to monitor VivoSim Labs Inc. with trend dashboardsReal-Time Investment Picks with Accuracy - Newser
Analyzing net buyer seller activity in VivoSim Labs Inc.Intraday Price Forecast Using Volume Models - Newser
Detecting price anomalies in VivoSim Labs Inc. with AIBuy Zone Strategy with Pattern Recognition - Newser
Will VivoSim Labs Inc. stock go up soonAI Trade Signal Forecast with Chart Logic - Newser
Wyckoff Accumulation Phase Possible in VivoSim Labs Inc.Risk Adjusted Technical Entry Plan Gains Followers - beatles.ru
What makes VivoSim Labs Inc. stock price move sharplyFree Wealth Building Stock Market Ideas - Newser
Key resistance and support levels for VivoSim Labs Inc.Free Step-by-Step Trade Signal Implementation - Newser
What institutions are buying VivoSim Labs Inc. stock nowControlled Entry Strategy With Safety Analytics - Newser
What moving averages say about VivoSim Labs Inc.Community Picked Stocks with Trade Insights - Newser
Using data models to predict VivoSim Labs Inc. stock movementAlpha Stock Picks with Chart Confirmation - Newser
Should you hold or exit VivoSim Labs Inc. nowBuy Entry Confirmation Based on Technical Analysis - Newser
Real time scanner hits for VivoSim Labs Inc. explainedEquity Market Return Forecast Model Update - Newser
How high can VivoSim Labs Inc. stock price go in 2025Free Stock Market Watch With Alerts - Newser
What is VivoSim Labs Inc. company’s growth strategyUnstoppable profit momentum - Jammu Links News
Vivosim Labs Inc Stock (VIVS) Financials Data
There is no financial data for Vivosim Labs Inc (VIVS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.91%
3.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):